Cargando…

Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study

BACKGROUND AND OBJECTIVES: Approximately 10% of patients with glioma with epilepsy need antiseizure medication (ASM) triple therapy due to refractory epilepsy. The aim of this study was to evaluate whether levetiracetam combined with valproic acid and clobazam (LEV + VPA + CLB), a frequently prescri...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Meer, Pim B., Dirven, Linda, Fiocco, Marta, Vos, Maaike J., Kouwenhoven, Mathilde C.M., van den Bent, Martin J., Taphoorn, Martin J.B., Koekkoek, Johan A.F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104607/ https://www.ncbi.nlm.nih.gov/pubmed/36754633 http://dx.doi.org/10.1212/WNL.0000000000206852

Ejemplares similares

Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2022)

Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study
por: van der Meer, Pim B., et al.
Publicado: (2023)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

First‐line levetiracetam versus enzyme‐inducing antiseizure medication in glioma patients with epilepsy
por: van der Meer, Pim B., et al.
Publicado: (2022)

Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome
por: van der Meer, Pim B, et al.
Publicado: (2020)

Management of epilepsy in brain tumor patients
por: van der Meer, Pim B., et al.
Publicado: (2022)

The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide
por: van Opijnen, Mark P., et al.
Publicado: (2021)

The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective Study
por: Peeters, Marthe C.M., et al.
Publicado: (2020)

Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review
por: de Bruin, Marjolein E, et al.
Publicado: (2021)

Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints
por: van der Meer, Pim B., et al.
Publicado: (2021)

Prediagnostic presentations of glioma in primary care: a case–control study
por: Peeters, Marthe CM, et al.
Publicado: (2019)

Prescription preferences of antiepileptic drugs in brain tumor patients: An international survey among EANO members
por: van der Meer, Pim B, et al.
Publicado: (2021)

Research Objectives, Statistical Analyses and Interpretation of Health-Related Quality of Life Data in Glioma Research: A Systematic Review
por: Coomans, Marijke B., et al.
Publicado: (2020)

Evaluating the lack of impact of the e-health application Oncokompas on outcomes in incurably ill cancer patients
por: Dirven, Linda, et al.
Publicado: (2022)

Is the EORTC QLQ‐C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
por: Oort, Quirien, et al.
Publicado: (2022)

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study
por: Koekkoek, Johan A F, et al.
Publicado: (2014)

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study
por: Kerkhof, M., et al.
Publicado: (2019)

Advance care planning in glioblastoma patients: development of a disease-specific ACP program
por: Fritz, Lara, et al.
Publicado: (2019)

Drug repositioning in epilepsy reveals novel antiseizure candidates
por: Brueggeman, Leo, et al.
Publicado: (2018)

Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy
por: Hersi, Hire, et al.
Publicado: (2022)

Epilepsy, Antiseizure Therapy, and Sleep Cycle Parameters
por: Shvarts, Vladimir, et al.
Publicado: (2013)

Health-related quality of life in high-grade glioma patients
por: Dirven, Linda, et al.
Publicado: (2014)

Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2020)

The long-term caregiver burden in World Health Organization grade I and II meningioma: It is not just the patient
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2020)

Determinants and predictors for the long-term disease burden of intracranial meningioma patients
por: Zamanipoor Najafabadi, Amir H., et al.
Publicado: (2020)

Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2021)

The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review
por: van Opijnen, Mark P., et al.
Publicado: (2019)

Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy
por: van der Meer, Pim B., et al.
Publicado: (2018)

Association between addressing antiseizure drug side effects and patient-reported medication adherence in epilepsy
por: Moura, Lidia M V R, et al.
Publicado: (2016)

Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy
por: Willems, Laurent M., et al.
Publicado: (2023)

Influence of Different Antiseizure Medications on Vascular Risk Factors in Children with Epilepsy
por: Mahrous, Doaa M., et al.
Publicado: (2022)

Neurocognitive impairment and patient–proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients
por: Caramanna, Ivan, et al.
Publicado: (2022)

Advance Care Planning in Glioblastoma Patients
por: Fritz, Lara, et al.
Publicado: (2016)

Research Progress on the Effect of Epilepsy and Antiseizure Medications on PCOS Through HPO Axis
por: Li, Shuang, et al.
Publicado: (2021)

Brain tumor related epilepsy: pathophysiological approaches and rational management of antiseizure medication
por: Seidel, Sabine, et al.
Publicado: (2022)

Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy
por: Döring, Jan H., et al.
Publicado: (2022)

Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy
por: Terman, Samuel W., et al.
Publicado: (2022)

Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Epilepsy and Their Interaction with Antiseizure Medications
por: Tesiye, Maryam Rahimi, et al.
Publicado: (2022)

Effect of clinical features on antiseizure medication doses in patients with newly diagnosed epilepsy
por: Hersi, Hire, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bk3b80r8kovh6ki8tvqm16q3oi